Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Minority Interest (2016 - 2026)

Cumberland Pharmaceuticals' Minority Interest history spans 16 years, with the latest figure at -$336100.0 for Q4 2025.

  • On a quarterly basis, Minority Interest fell 9.29% to -$336100.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$336100.0, a 9.29% decrease, with the full-year FY2025 number at -$336100.0, down 9.29% from a year prior.
  • Minority Interest hit -$336100.0 in Q4 2025 for Cumberland Pharmaceuticals, down from -$319150.0 in the prior quarter.
  • Over the last five years, Minority Interest for CPIX hit a ceiling of -$139283.0 in Q1 2021 and a floor of -$343572.0 in Q4 2023.
  • Historically, Minority Interest has averaged -$277751.6 across 5 years, with a median of -$308605.5 in 2024.
  • Biggest five-year swings in Minority Interest: tumbled 195.44% in 2021 and later grew 10.49% in 2024.
  • Tracing CPIX's Minority Interest over 5 years: stood at -$212328.0 in 2021, then plummeted by 37.58% to -$292126.0 in 2022, then decreased by 17.61% to -$343572.0 in 2023, then increased by 10.49% to -$307517.0 in 2024, then fell by 9.29% to -$336100.0 in 2025.
  • Business Quant data shows Minority Interest for CPIX at -$336100.0 in Q4 2025, -$319150.0 in Q3 2025, and -$310868.0 in Q2 2025.